<bill session="115" type="s" number="2608" updated="2023-01-11T13:39:57Z">
  <state datetime="2018-03-22">REFERRED</state>
  <status>
    <introduced datetime="2018-03-22"/>
  </status>
  <introduced datetime="2018-03-22"/>
  <titles>
    <title type="display">Reducing Opioid Risk Act</title>
    <title type="official" as="introduced">A bill to provide that a risk evaluation and mitigation strategy communication plan may include information about Federal and State prescribing requirements for controlled substances.</title>
    <title type="short" as="introduced">Reducing Opioid Risk Act</title>
  </titles>
  <sponsor bioguide_id="W000817"/>
  <cosponsors>
    <cosponsor bioguide_id="C001047" joined="2018-03-22"/>
  </cosponsors>
  <actions>
    <action datetime="2018-03-22">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2018-03-22" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="115" type="s" number="2680" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Health personnel"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2019-08-20T17:01:00Z" status="Introduced in Senate">Reducing Opioid Risk Act

This bill amends the Federal Food, Drug, and Cosmetic Act to expand the authority of the Food and Drug Administration to require a drug manufacturer to inform health care providers about state and federal regulations for controlled substances, including the partial fill option.</summary>
</bill>
